Baxdrostat Slashes BP in Resistant Hypertension: BrigHTN

The novel agent lowers aldosterone activity without the off-target inhibition of cortisol synthesis that has thwarted previous drug candidates, the researchers say.

Related Keywords

United States ,American ,Cincor Pharma ,Suzanne Oparil ,Masonw Freeman ,American Heart Association Scientific Sessions ,University Of Alabama At Birmingham ,New England Journal ,Vascular Biology ,Hypertension ,Blood ,Resistant Hypertension ,Esistant Htn ,Antihypertensive ,Adverse Effects ,Side Effects ,Arrhythmia ,Hyperkalemia ,Patient Safety ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Renal Failure ,Enal Insufficiency ,Idney Insufficiency ,Kidney Failure ,Calcium Channel Blockers ,Renal Disease ,Kidney Disease ,Kidney Disorder ,Mena ,